Editas Medicine (EDIT) Research & Development: 2015-2025
Historic Research & Development for Editas Medicine (EDIT) over the last 11 years, with Sep 2025 value amounting to $19.8 million.
- Editas Medicine's Research & Development fell 58.49% to $19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.2 million, marking a year-over-year decrease of 49.52%. This contributed to the annual value of $199.2 million for FY2024, which is 12.16% up from last year.
- Editas Medicine's Research & Development amounted to $19.8 million in Q3 2025, which was up 22.21% from $16.2 million recorded in Q2 2025.
- Over the past 5 years, Editas Medicine's Research & Development peaked at $69.6 million during Q4 2023, and registered a low of $16.2 million during Q2 2025.
- Moreover, its 3-year median value for Research & Development was $40.5 million (2023), whereas its average is $39.9 million.
- Per our database at Business Quant, Editas Medicine's Research & Development spiked by 82.04% in 2024 and then slumped by 70.15% in 2025.
- Over the past 5 years, Editas Medicine's Research & Development (Quarterly) stood at $37.6 million in 2021, then skyrocketed by 38.47% to $52.0 million in 2022, then skyrocketed by 33.77% to $69.6 million in 2023, then slumped by 30.11% to $48.6 million in 2024, then tumbled by 58.49% to $19.8 million in 2025.
- Its last three reported values are $19.8 million in Q3 2025, $16.2 million for Q2 2025, and $26.6 million during Q1 2025.